Eli Total Cash From Operating Activities from 2010 to 2024

LLY Stock  USD 795.35  7.16  0.91%   
Eli Lilly Total Cash From Operating Activities yearly trend continues to be fairly stable with very little volatility. Total Cash From Operating Activities is likely to outpace its year average in 2024. During the period from 2010 to 2024, Eli Lilly Total Cash From Operating Activities regression line of annual values had r-squared of  0.09 and arithmetic mean of  5,110,160,343. View All Fundamentals
 
Total Cash From Operating Activities  
First Reported
1989-09-30
Previous Quarter
1.5 B
Current Value
3.7 B
Quarterly Volatility
715.6 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Eli Lilly financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eli Lilly's main balance sheet or income statement drivers, such as Depreciation And Amortization of 941.5 M, Interest Expense of 510.2 M or Total Revenue of 35.8 B, as well as many indicators such as Price To Sales Ratio of 16.21, Dividend Yield of 0.0073 or PTB Ratio of 51.34. Eli financial statements analysis is a perfect complement when working with Eli Lilly Valuation or Volatility modules.
  
Check out the analysis of Eli Lilly Correlation against competitors.

Latest Eli Lilly's Total Cash From Operating Activities Growth Pattern

Below is the plot of the Total Cash From Operating Activities of Eli Lilly and over the last few years. It is Eli Lilly's Total Cash From Operating Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eli Lilly's overall financial position and show how it may be relating to other accounts over time.
Total Cash From Operating Activities10 Years Trend
Slightly volatile
   Total Cash From Operating Activities   
       Timeline  

Eli Total Cash From Operating Activities Regression Statistics

Arithmetic Mean5,110,160,343
Geometric Mean4,703,293,470
Coefficient Of Variation33.09
Mean Deviation1,250,375,634
Median5,304,800,000
Standard Deviation1,690,936,645
Sample Variance2859266.7T
Range6.2B
R-Value0.29
Mean Square Error2814235.5T
R-Squared0.09
Significance0.29
Slope110,916,200
Total Sum of Squares40029734.3T

Eli Total Cash From Operating Activities History

20244.3 B
20234.2 B
20227.1 B
20217.3 B
20206.5 B
20194.8 B
20185.5 B

About Eli Lilly Financial Statements

Eli Lilly investors use historical fundamental indicators, such as Eli Lilly's Total Cash From Operating Activities, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Eli Lilly. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Cash From Operating Activities4.2 B4.3 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Eli Stock Analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.